ArticleJournal of biochemical and molecular toxicology2026
Curcumin Attenuates Aroclor 1254-Induced Oxidative, Genotoxic, and Apoptotic Alterations in HepG2 Cells.
Article in Journal of biochemical and molecular toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polychlorinated biphenyls (PCBs), particularly Aroclor 1254 (A1254), are persistent environmental contaminants with hepatotoxic, genotoxic, and pro-oxidant properties. The liver, as the main organ for xenobiotic metabolism, is highly vulnerable to PCB-induced oxidative stress and DNA damage. Curcumin, a polyphenolic compound from Curcuma longa, exhibits potent antioxidant, anti-inflammatory, and cytoprotective effects. This study investigated the oxidative, genotoxic, apoptotic, and mutagenic effects of A1254 in HepG2 cells and evaluated curcumin's protective potential. Cells were exposed to sub-cytotoxic concentrations of A1254 (2.5-25 µM), curcumin (0.5-2 µM), and their combinations. ROS levels, antioxidant enzyme activities, oxidative biomarkers, and total antioxidant capacity were measured. DNA damage was assessed via 8-hydroxy-2'-deoxyguanosine (8-OHdG), 8-oxoguanine glycosylase (OGG1), and Comet assays. Apoptosis was evaluated by caspase-3 and -8 activities, and mutagenicity via Ames (TA98/TA100) and HPRT assays. A1254 disrupted redox homeostasis, elevating ROS and oxidative damage while depleting glutathione, thiols, and enzymatic antioxidants. Curcumin co-treatment restored antioxidant defenses and mitigated oxidative damage. Genotoxicity induced by A1254, indicated by increased 8-OHdG and DNA strand breaks, was markedly reduced by curcumin, which also attenuated apoptotic responses. These results demonstrate that A1254 exerts multifaceted cytotoxicity via oxidative stress, DNA damage, apoptosis, and mutagenicity, and that curcumin effectively ameliorates these effects, supporting its potential as a hepatoprotective and genoprotective agent against PCB-induced toxicity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.